Core Viewpoint - The stock of Giant Bio (02367) has rebounded over 6%, currently trading at 40.1 HKD with a transaction volume of 411 million HKD, following the approval of its first medical aesthetic product, a type I collagen freeze-dried fiber for facial dermal filling [1] Group 1: Product Development - Giant Bio's first medical aesthetic product, a type I collagen freeze-dried fiber, has been approved for use in correcting dynamic facial wrinkles, including frown lines, forehead lines, and crow's feet [1] - The company is currently developing three additional medical aesthetic products, which include facial hydration, neck wrinkle treatments, and volumizing fillers [1] Group 2: Market Analysis - According to Guotai Junan Securities, the main brand, Kefu Mei, has seen a decline in its Double Eleven ranking due to public sentiment, product structure, and competition, which may lead to temporary pressure on the skincare business [1] - Despite the challenges, the company has strong brand equity and operational foundations, with a focus on future channel adjustments and new product launches [1] Group 3: Growth Potential - The newly approved collagen product is expected to contribute to a second growth curve for the company, given its anti-aging and repair benefits, along with a solid recognition of its ingredients [1] - The company has a foundational presence in the medical aesthetic channel, which positions it well for the product's market introduction [1]

Core Viewpoint - The recent surge in stock prices, particularly for China Duty Free Group (中国中免), has a significant positive impact on the entire consumer sector, demonstrating strong market sentiment and potential growth opportunities [1][4]. Group 1: Market Performance - China Duty Free Group's A-shares hit the daily limit, while its H-shares rose over 12%, indicating strong investor confidence [1]. - The consumer sector saw widespread gains, with companies like Huanlejia and Kweichow Moutai also reaching their daily limits, reflecting a robust market trend [1][5]. Group 2: Positive News Drivers - Three major positive factors are stimulating the consumer sector: 1. The Ministry of Finance's report on November 7 indicates continued implementation of policies to boost consumption, including financial incentives for personal consumption loans [2][8]. 2. Positive signals in the economic fundamentals, with October's CPI showing a month-on-month increase of 0.2% and a year-on-year increase of 0.2%, alongside a core CPI increase to 1.2% [2][9]. 3. The upcoming full closure of Hainan on December 18 is expected to usher in a new development phase, enhancing trade convenience and tax benefits, which could significantly boost the duty-free market [2][10]. Group 3: Economic Indicators - The CPI's year-on-year improvement from -0.3% in September to 0.2% in October suggests a gradual recovery in consumer demand [9]. - The expansion of duty-free product categories in Hainan and the increase in shopping amounts and visitors indicate a strong recovery in the duty-free market, with a reported shopping amount of 5.06 billion yuan and a 34.86% year-on-year increase [9][10].

Group 1 - The core viewpoint of the news highlights the strong performance of the Hong Kong consumer sector, with the Hong Kong consumer ETF rising over 2% and key holdings such as Pop Mart, Great Wall Motors, and others showing significant gains [1] - The implementation of the new duty-free shopping policy in Hainan during its first week (November 1-7) resulted in a total duty-free shopping amount of 506 million yuan and 72,900 shoppers, reflecting year-on-year increases of 34.86% and 3.37% respectively [1] - The new policy has stimulated consumption effectively, with notable sales in new categories such as pet supplies and portable musical instruments, indicating a positive response from both travelers and local residents [1] Group 2 - The new duty-free shopping policy not only revitalizes the Hainan consumer market but also injects new growth momentum into the local retail and tourism industries, providing data support for future policy optimization [1] - Related popular ETFs include tourism ETFs benefiting from holiday catalysts and the ice and snow economy, food and beverage ETFs aimed at boosting domestic demand, and the Hong Kong consumer ETF linked to e-commerce leaders and new consumption trends [2]

Group 1 - The Hong Kong stock market opened higher on November 10, with the consumer sector showing strong performance, particularly the Hong Kong Consumer ETF (513230) which rose over 2% [1] - Key stocks within the ETF, such as Pop Mart and Great Wall Motors, led gains of over 7%, while other companies like Samsonite, Gu Ming, and BYD also saw increases of over 4% [1] - The National Bureau of Statistics released October inflation data, indicating a 0.2% month-on-month and year-on-year increase in the Consumer Price Index (CPI), with the core CPI rising 1.2% year-on-year, marking the sixth consecutive month of growth [1] Group 2 - Huajin Securities noted that the October inflation data reflects a continued improvement in both core CPI and Producer Price Index (PPI), with the PPI showing a 0.1% month-on-month increase, the first rise this year [1] - The report highlighted that the recovery in service consumption, rising gold prices, and higher food prices contributed to the positive CPI trend, while the narrowing decline in PPI was attributed to the "anti-involution" trend [1] - The necessity of expanding domestic demand to solidify the domestic supply-demand cycle has become more prominent, with expectations for greater fiscal expansion by the central government in 2026 to boost consumption and effective investment [1] Group 3 - The Hong Kong Consumer ETF (513230) tracks the CSI Hong Kong Stock Connect Consumer Theme Index, encompassing a wide range of consumer sectors, including leading new consumption brands and internet e-commerce giants [2] - The ETF includes major players such as Pop Mart, Lao Pu Gold, and Miniso, as well as tech and e-commerce leaders like Tencent, Kuaishou, Alibaba, and Xiaomi, highlighting its strong technology and consumer attributes [2]

Investment Rating - The report maintains a "Buy" rating for several companies in the pharmaceutical sector, indicating a potential upside of over 15% in the next 12 months [30]. Core Insights - The MSCI China Healthcare Index has increased by 59.5% since early 2025, outperforming the MSCI China Index by 24.0%. However, the healthcare sector has recently experienced a 10% pullback, presenting opportunities in undervalued stocks [1]. - The report emphasizes the importance of overseas clinical advancements for authorized innovative drug pipelines, which are expected to be significant catalysts for stock price increases [3]. - The report highlights a recovery in domestic innovative drug research and development demand, driven by a resurgence in capital market financing and an increase in the scale of innovative drug transactions abroad [1][3]. Summary by Sections Industry Overview - The report suggests a more conservative investment approach, focusing on undervalued stocks within the pharmaceutical sector. It notes that the recent healthcare insurance negotiations and the implementation of the 11th batch of centralized procurement have led to reduced market attention [3]. - The report identifies key products to watch in the upcoming healthcare negotiations, including drugs from companies like 信达生物 and 康方生物, among others [3]. Company Recommendations - The report recommends buying shares in 三生制药, 固生堂, 巨子生物, 药明合联, 信达生物, and 中国生物制药, citing their strong potential for growth and favorable market conditions [3]. - Specific companies are highlighted for their promising clinical trial results and strategic partnerships, such as 三生制药's collaboration with Pfizer on global clinical trials [3]. Valuation Metrics - The report provides a valuation table for recommended companies, showing target prices and potential upside percentages. For example, 固生堂 has a target price of 48.28 with a 62% upside potential [2].

Group 1 - The Hong Kong stock market opened higher on November 10, with the consumer sector showing significant gains, particularly the Hong Kong Consumer ETF (159735), which rose by 1.44% during trading [1] - Notable stocks within the ETF included Pop Mart, Great Wall Motors, which both increased by over 3%, along with other companies like Giant Bio, Tencent Holdings, and China Resources Beer also seeing upward movement [1] - As of November 7, the Hong Kong Consumer ETF (159735) has seen a nearly 140% increase in its year-to-date share volume [1] Group 2 - The National Bureau of Statistics released October price data indicating a month-on-month increase of 0.2% in the Consumer Price Index (CPI) and a year-on-year increase of 0.2%, with the core CPI (excluding food and energy) rising by 1.2%, marking the sixth consecutive month of growth [1] - The Producer Price Index (PPI) also showed a month-on-month increase of 0.1%, marking its first rise of the year [1] - Changjiang Securities noted that the rise in CPI and PPI is attributed to seasonal factors, low base effects, and the "anti-involution" trend, with expectations for continued strength in CPI towards the end of the year [2] - Huajin Securities highlighted that the improvement in core CPI and PPI reflects stable growth in service consumption and rising food prices, while the "anti-involution" trend has led to a narrowing of PPI declines [2]

1. Report Industry Investment Rating - The industry rating is "Bullish" [1] 2. Core Views of the Report - The cosmetics industry continues to show differentiation, with brand demand being weak in the off - season, agents seeking change in difficult situations, and producers seizing supply - chain reconstruction opportunities. The medical aesthetics industry has new entrants with better - than - expected shipments, and new product catalysts are worth attention [3][4] 3. Summaries According to Relevant Catalogs 3.1 Cosmetics: Continued Differentiation 3.1.1 Brand Merchants - In 1 - 3Q25, beauty brand merchants' revenue was 28.4 billion yuan, a year - on - year decrease of 0.6%; personal care brand merchants' revenue was 5.7 billion yuan, a year - on - year increase of 12.4%. In 3Q25, beauty and personal care brand merchants' revenues were 8.05 billion and 1.805 billion yuan, a year - on - year decrease of 1.3% and an increase of 7.6% respectively. Beauty revenue weakened quarter - on - quarter, while personal care remained flat [18] - Beauty: Affected by the earlier Double Eleven promotion, consumer enthusiasm declined in September, and brands reduced live - streaming activities. In terms of single - quarter revenue growth, Shuiyang Co., Ltd. and Shanghai Jahwa increased by over 20%, Marubi Co., Ltd. had double - digit growth, Proya had low - double - digit decline, and Betaine and Freda had high - single - digit decline [18] - Personal care: Runben Co., Ltd.'s Q3 revenue increased by 17% year - on - year, with a slight increase in growth rate quarter - on - quarter. Baiya Co., Ltd.'s 3Q25 revenue improved, and Dengkang Oral Care had steady growth [18] - In 1 - 3Q25, beauty brand merchants' net profit after non - recurring items was 2.33 billion yuan, a year - on - year decrease of 15%; personal care brand merchants' was 604 million yuan, a year - on - year decrease of 3.4%. Some companies showed initial cost - control effects [24] 3.1.2 Agents - Agents are seeking change in difficult situations by exploring three paths: incubating self - owned brands (represented by Ruoyuchen), using AI to reduce costs and increase efficiency (represented by Yiwow), and expanding high - growth categories (such as Qingmu Technology expanding into trendy toy agency operations) [30] - Ruoyuchen's self - owned brands Feicui and Zhanjia continued to gain momentum. In Q3, self - owned brand revenue was 451 million yuan, a year - on - year increase of 344.5%, accounting for 55.1%. Zhanjia's Q3 revenue was 227 million yuan, a year - on - year increase of 119%, and 1 - 3Q revenue was 680 million yuan. Feicui's Q3 revenue was 203 million yuan, a quarter - on - quarter increase of over 98.8%, and 1 - 3Q revenue was 362 million yuan [30] 3.1.3 Producers - Demand continued to recover, and the revenue of the producer sector increased by 9%, 17%, and 30% year - on - year from Q1 to Q3, with the growth rate increasing quarter by quarter [33] - QingSong Co., Ltd. focused on optimizing customers and product structure, and its profit turned positive for four consecutive quarters from 2Q24 to 1Q25. Jieya Co., Ltd. had increasing orders from overseas big customers, and its Q3 performance growth accelerated. Jiaheng Home Co., Ltd. increased revenue but not profit, mainly due to the short - term impact of the Huzhou base's capacity ramp - up [33] 3.2 Medical Aesthetics: New Entrants with Better - than - Expected Shipments 3.2.1 Upstream Consumables - The growth rate of demand expansion slowed down, and supply - side competition intensified. In terms of the cumulative number of Class III medical device approvals, hyaluronic acid > regenerative (Sculptra/Poly - L - Lactic Acid) > botulinum toxin > recombinant collagen. Old products of hyaluronic acid and regenerative types faced growth pressure, and the growth rate of recombinant collagen Class III medical device products slowed down significantly quarter - on - quarter [38] - Hyaluronic acid: Aimeike's revenue growth rate from 24Q1 to 25Q3 was + 28.2%/+2.3%/+1.1%/ - 7%/ - 18%/ - 25%/ - 21% year - on - year, showing a quarterly decline since 24Q2 [38] - Collagen: Jinbo Biotech's revenue growth rate from 24Q1 to 25Q1 was + 76%/+100%/+92%/+73%/+63% year - on - year, and in 2Q25/3Q25, it was + 30%/+13% year - on - year. On October 23, the "Recombinant Type I α1 Subtype Collagen Freeze - Dried Fiber" Class III medical device certificate of Giant Biogene was approved by NMPA [38] - Leapmed Medical's medical aesthetics shipments were better than expected, with Q3 medical service and health management business revenue of 320 million yuan, a year - on - year increase of 28%, and the revenue of Sculptra and Hydrodermabrasion reaching 86.1367 million yuan [36] 3.2.2 Downstream - The new model of Xinoxygen Medical Clinics showed high - growth potential. The Q3 revenue guidance was 150 - 170 million yuan, a year - on - year increase of 231% - 275%, and a quarter - on - quarter increase of 4% - 18%. It plans to implement the "100 - City, 1000 - Store" plan in the long term [40] - Stores are expanding from first - tier cities to new first - tier and second - tier cities. As of November 6, it covered 42 stores in 10 cities. The promotion of self - owned brands was remarkable, and it cooperated with Xihong Miracle Sculptra 3.0, priced at 2999 yuan, which was officially launched on September 25 [43] 3.3 Investment Recommendations - Brands with upward potential and both growth and certainty: Recommend Maogeping (Oriental aesthetics, dual - wheel drive of makeup and skincare, and the second - curve of perfume is worth looking forward to) and Shangmei Co., Ltd. (with one cornerstone brand, five growth brands, and N seed businesses) [8][46] - Companies with new product pipelines and expected performance elasticity: Pay attention to Giant Biogene and Leapmed Medical [8][46] - Companies in strategic adjustment and expected to reach an inflection point: Recommend Shuiyang Co., Ltd. (the effect of high - end transformation is gradually emerging), and pay attention to Shanghai Jahwa, Betaine, and Freda [8][46]

Group 1 - The report highlights the significant achievements in the recent China-US trade talks, with the US agreeing to suspend certain tariffs on Chinese goods, which may positively impact trade dynamics [7] - The macroeconomic policy emphasizes the importance of expanding domestic demand and improving living standards, as outlined in the "15th Five-Year Plan" [5][6] - The report notes a shift in export growth, with October exports showing a decline of 1.1% year-on-year, influenced by high base effects from the previous year [11][12] Group 2 - The report discusses the rebalancing between technology and cyclical sectors, suggesting that both will play significant roles in the market moving forward [17][20] - It identifies the satellite industry as a strategic investment opportunity, driven by large market potential, strong policy support, and technological advancements [23][24] - The report indicates that the REIT market is showing resilience, with the recent listing of the CITIC Construction Investment Shenyang International Software Park REIT, which is expected to attract investment due to its high dividend yield [65][66]

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Insights - The introduction of new tax policies for gold is expected to drive market share towards leading brands in the medium to long term. The new tax policy exempts value-added tax for standard gold transactions, which may lead to increased costs for non-investment gold products, ultimately raising retail prices and potentially suppressing consumer demand in the short term. However, this policy is anticipated to regulate the industry and strengthen the competitive advantage of compliant leading brands [5]. - Domestic beauty brands are beginning to establish a presence on video platforms, with significant growth in the social e-commerce sector. The GMV of WeChat mini-programs is expected to exceed 2.5 trillion yuan in 2025, with social e-commerce accounting for over 50% of total transactions. Brands that leverage this platform effectively may maintain competitive advantages [5]. - The report emphasizes the importance of understanding new consumer narratives shaped by younger generations, suggesting a focus on high-quality domestic brands in beauty, gold jewelry, trendy toys, and tea beverages [22]. Summary by Sections Industry Performance - The new consumption sector showed varied performance, with the beauty and personal care sector declining by 3.10%, while the retail index increased by 0.31% during the week of November 3 to November 7, 2025 [8]. Key Industry Data - In September, retail sales for clothing and textiles increased by 4.7%, cosmetics by 8.6%, and gold and silver jewelry by 9.7%. However, beverage retail sales saw a decline of 0.8% [12][16]. Investment Analysis Recommendations - The report recommends focusing on high-quality domestic brands with strong innovation in beauty, such as Mao Ge Ping and Shangmei; leading brands in traditional gold jewelry favored by younger consumers, such as Laopu Gold and Chaohongji; companies with successful IP creation and operation experience in trendy toys, like Pop Mart; and strong tea beverage brands with extensive market coverage, such as Mixue Group and Guming [22].

Core Insights - The retail industry is experiencing a shift from value preservation to emotional value, with a focus on high-growth segments for investment opportunities [5][28] - The report maintains a positive outlook on the retail sector, emphasizing the importance of consumer insights and differentiated product offerings [5][28] Retail Market Overview - The retail index reported a slight increase of 0.31% during the week of November 3 to November 7, 2025, underperforming the Shanghai Composite Index, which rose by 1.08% [7][16] - Year-to-date, the retail index has increased by 4.20%, lagging behind the Shanghai Composite Index's 19.27% growth [16][20] Investment Strategy for 2026 - The investment strategy highlights four main themes: 1. **Gold and Jewelry**: Focus on high-end and fashionable gold segments, with recommendations for brands like Lao Pu Gold and Chao Hong Ji [5][48] 2. **Retail E-commerce**: Emphasize the transformation of offline retail to enhance service and experience, with key players like Yonghui Supermarket and Ai Ying Shi [5][48] 3. **Cosmetics**: Target domestic brands that capture emotional value and innovate on safety ingredients, recommending brands like Juzi Biological and Pechoin [5][49] 4. **Medical Aesthetics**: Focus on differentiated product manufacturers and expanding medical institutions, with recommendations for brands like Ai Mei Ke and Ke Di-B [5][49] Sector Performance - The jewelry sector is undergoing significant changes due to rising gold prices and a decline in traditional wedding markets, leading to the emergence of brands with strong consumer insights [5][29] - The cosmetics sector is seeing a rise in domestic brands leveraging cultural roots and emotional value to capture market share [5][41] Company-Specific Insights - **Chao Hong Ji**: Reported a revenue increase of 28.4% year-on-year for the first three quarters of 2025, with a notable performance in Q3 [54] - **Yonghui Supermarket**: Experienced a revenue decline of 22.2% year-on-year for the first three quarters of 2025, but is undergoing significant transformation [50] - **Juzi Biological**: Achieved a revenue growth of 21.7% year-on-year for the first half of 2025, focusing on collagen products [50]